The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages

  Verkleij, Chantal J N ^a   De Bruijn, Roderick E ^b   Meesters, Eelco W ^b   Gerdes, Victor E A ^a,b   Meijers, Joost C M ^a   Marx, Pauline F ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

cardiovascular disease; coagulation; fibrinolysis; hemostasis; type 2 diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; VON WILLEBRAND FACTOR;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPOFIBRINOLYSIS; INSULIN TREATMENT; ISCHEMIC CARDIOMYOPATHY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84857212868     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610384112     Document Type: Article

References (14)

1. Grant PJ.. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007 ; 262 (2). 157-172 (Pubitemid 47090159)
2. Dunn EJ, Grant PJ.. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med. 2005 ; 5 (3). 323
3. Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P.. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients-relationship with plasma insulin. Thromb.Haemost. 1989 ; 61 (3). 370-373 (Pubitemid 19168139)
4. Standl E, Balletshofer B, Dahl B, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia. 1996 ; 39 (12). 1540-1545 (Pubitemid 26397365)
5. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R.. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care. 1995 ; 18 (1). 87-89
6. Erem C, Hacihasanoglu A, Celik S, et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract. 2005 ; 14 (1). 22-30
7. Fuller JH, Keen H, Jarrett RJ, et al. Haemostatic variables associated with diabetes and its complications. Br Med J. 1979 ; 2 (6196). 964-966 (Pubitemid 10244349)
8. Mansfield MW, Heywood DM, Grant PJ.. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation. 1996 ; 94 (9). 2171-2176 (Pubitemid 26360510)
9. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR.. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J. 1990 ; 120 (3). 672-676 (Pubitemid 20312600)
10. Mansfield MW, Stickland MH, Grant PJ.. PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations. Thromb Haemost. 1997 ; 77 (2). 357-361 (Pubitemid 27084930)
11. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987 ; 2 (8549). 3-9 (Pubitemid 17083665)
12. Mosnier LO, Von dem Borne PA, Meijers JC, Bouma BN.. Plasma TAFI levels determine the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost. 1998 ; 80 (5). 829-835 (Pubitemid 28521730)
13. Willemse J, Leurs J, Verkerk R, Hendriks D.. Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Anal.Biochem. 2005 ; 340 (1). 106-112 (Pubitemid 40404106)
14. Knobl P, Schernthaner G, Schnack C, et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993 ; 36 (10). 1045-1050 (Pubitemid 23288774)